STEADYMED LTD. (STDY) financial statements (2020 and earlier)

Company profile

Business Address 5 OPPENHEIMER STREET
REHOVOT, 76701
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments322332
Cash and cash equivalents322332
Restricted cash and investments000
Receivables  0
Prepaid expense  0
Other undisclosed current assets000
Total current assets:332332
Noncurrent Assets
Property, plant and equipment553
Deposits noncurrent assets000
Assets held-in-trust000
Total noncurrent assets:653
TOTAL ASSETS:382835
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities132
Accrued liabilities121
Employee-related liabilities111
Debt  0
Deferred revenue and credits 12
Other undisclosed current liabilities132
Total current liabilities:366
Noncurrent Liabilities
Liabilities, other than long-term debt101
Deferred revenue and credits  0
Accounts payable and accrued liabilities000
Liability, pension and other postretirement and postemployment benefits000
Other undisclosed noncurrent liabilities117 
Total noncurrent liabilities:1271
Total liabilities:15147
Stockholders' equity
Stockholders' equity attributable to parent241429
Common stock000
Additional paid in capital13610392
Accumulated deficit(112)(89)(63)
Total stockholders' equity:241429
TOTAL LIABILITIES AND EQUITY:382835

Income statement (P&L) ($ in millions)

12/31/2017
12/31/2016
12/31/2015
Gross profit:111
Operating expenses(22)(28)(26)
Operating loss:(20)(27)(25)
Nonoperating income (expense)(3)20
Investment income, nonoperating000
Foreign currency transaction gain, before tax 00
Interest and debt expense(3)(1) 
Loss from continuing operations before equity method investments, income taxes:(26)(26)(25)
Other undisclosed income from continuing operations before income taxes31 
Loss from continuing operations before income taxes:(23)(25)(25)
Income tax expense(0)(0)(0)
Net loss attributable to parent:(23)(26)(25)
Preferred stock dividends and other adjustments  (1)
Net loss available to common stockholders, diluted:(23)(26)(26)

Comprehensive Income ($ in millions)

12/31/2017
12/31/2016
12/31/2015
Net loss:(23)(26)(25)
Comprehensive loss, net of tax, attributable to parent:(23)(26)(25)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: